Sitagliptin, Sitagliptin- Metformin combination to be available at Janaushadhi Kendras at price range of Rs 60 - Rs 100 per pack
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
New Delhi: Chief Executive Officer of Pharmaceuticals & Medical Devices Bureau of India (PMBI) Shri Ravi Dadhich has launched Sitagliptin a new variant of medicines for diabetes at affordable prices for all under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. PMBI included new variants of medicines Sitagliptin and its combination in its all Jan Aushdhi Kendras viz.
Name of the Product MRP for Pack of 10
(1) Sitagliptin Phosphate Tablet IP 50mg Rs. 60/-
(2) Sitagliptin Phosphate Tablet IP 100mg Rs. 100/-
(3) Sitagliptin + Metformin Hydrochloride Tablets 50mg/500mg Rs. 65/-
(4) Sitagliptin + Metformin Hydrochloride Tablets 50mg/1000mg Rs. 70/-
Read also: Glenmark Pharma launches Sitagliptin and its FDCs for Type 2 diabetes in India
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves. The most common is type 2 diabetes, usually in adults, which occurs when the body becomes resistant to insulin or doesn't make enough insulin.
All these variants are available at 60% to 70% lesser prices than branded variants as they are available in price band of Rs. 162/- to Rs. 258/- at other medical stores.
Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, more than 8700 Pradhan Mantri Bhartiya Janaushadhi Kendras have been opened across the country. These Kendras are selling generic medicines, surgical equipment, nutraceuticals and other products. At present, these Kendras make available more than 1600 medicines and 250 surgical devices including Suvidha Sanitary pads which are sold at Rs. 1/- per pad.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.